The 2021 ASCO Annual Meeting will be held virtually on June 4-8.
Found below is the list of prostate cancer-related abstracts that will be featured at ASCO21. Don’t miss these highlights recommended by the UROONCO Editorial Board!
Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)